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Apolipoprotein E (APOE) ε genotype has previously been signiﬁcantly associated with cognitive, brain
imaging, and Alzheimer’s disease-related phenotypes (e.g., age of onset). In the TOMM40 gene, the
rs10524523 (“523”) variable length poly-T repeat polymorphism has more recently been associated with
similar ph/enotypes, although the allelic directions of these associations have varied between initial re-
ports. Using diffusion magnetic resonance imaging tractography, the present study aimed to investigate
whether there are independent effects of apolipoprotein E (APOE) and TOMM40 genotypes on human brain
white matter integrity in a community-dwelling sample of older adults, the Lothian Birth Cohort 1936
(mean age¼ 72.70 years, standard deviation¼ 0.74, N approximately¼ 640e650; formost analyses). Some
nominally signiﬁcant effects were observed (i.e., covariate-adjusted differences between genotype groups
at p < 0.05). For APOE, deleterious effects of ε4 “risk” allele presence (vs. absence) were found in the right
ventral cingulum and left inferior longitudinal fasciculus. To test for biologically independent effects of the
TOMM40 523 repeat, participants were stratiﬁed into APOE genotype subgroups, so that any signiﬁcant
effects could not be attributed to APOE variation. In participants with the APOE ε3/ε4 genotype, effects of
TOMM40 523 status were found in the left uncinate fasciculus, left rostral cingulum, left ventral cingulum,
and a general factor of white matter integrity. In all 4 of these tractography measures, carriers of the
TOMM40523 “short” allele showed lowerwhitematter integritywhen comparedwith carriers of the “long”
and “very-long” alleles. Most of these effects survived correction for childhood intelligence test scores and
vascular disease history, though only the effect of TOMM40 523 on the left ventral cingulum integrity
survived correction for false discovery rate. The effects of APOE in this older population are more speciﬁc
and restricted compared with those reported in previous studies, and the effects of TOMM40 on white
matter integrity appear to be novel, although replication is required in large independent samples.
 2014 The Authors. Published by Elsevier Inc. Open access under CC BY license.eing and Cognitive Epidemi-
8 9JZ, UK. Tel.: þ44 131 650
r Inc. Open access under CC BY license.1. Introduction
The apolipoprotein E (APOE) gene is located on chromosome
19q13.2 and is 3.7 kilobases (KB) long. APOE ε genotype is composed
of 2 single-nucleotide polymorphisms (SNPs): rs429358, which
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Arg176Cys substitution; different combinations of the rs429358
and/or rs7412 SNPs form the ε2 (Cys/Cys, respectively), ε3 (Cys/Arg),
and ε4 (Arg/Arg) genotypes (NCBI website, 2012a; Ringman and
Cummings, 2009). Of these, the ε3 allele is the most common
(frequencyw78.3% in Caucasians), followed by ε4 (w14.5%) and ε2
(w6.4%), although these frequencies vary between populations
(Eisenberg et al., 2010).
APOE plays a role in the transport andmetabolism of lipids in the
human body and brain (Bu et al., 2009; Corder et al., 1994). The ε4
allele of APOE is the “risk” variant for several phenotypes compared
with ε3 (“neutral”), and ε2 (generally considered “protective”,
although less consistently). These phenotypes include risk of Alz-
heimer’s disease (AD) (Corder et al., 1994), less successful cognitive
aging (Deary et al., 2004; Wisdom et al., 2011), differences in brain
structure (e.g., atrophy; Bifﬁ et al., 2010), and functional connec-
tivity (Trachtenberg et al., 2012); vascular pathologies such as
hyperlipidemia, coronary heart disease and stroke (Lahoz et al.,
2001), and brain microbleeds (Schilling et al., 2013). It is not clear
to what extent associations between APOE variants and worse
cognitive aging in cross-sectional and longitudinal studies reﬂect
preclinical “prodromal” AD (Bretsky et al., 2003; Deary et al., 2004).
There might be complexities in how the APOE ε4 allele is asso-
ciated with clinical onset of AD or cognitive decline (Johnson et al.,
2011). Other genetic variants aside from APOE, possibly in linkage
disequilibriumwith it, may play a role. The translocase of the outer
membrane of 40 (TOMM40) gene is located adjacent to APOE and
covers 12.5 KB on chromosome 19q13 (NCBI website, 2012b).
Several SNPs in the APOE and TOMM40 genes are in strong linkage
disequilibrium; for example, rs429358 and 36 SNPs within1.17 KB
of the APOE region including 15 TOMM40 SNPs; average D0 ¼ 0.91,
r2 ¼ 0.22, n ¼ 1262 (Yu et al., 2007). The TOMM40 locus encodes for
a channel-forming subunit of the translocase of the outer mito-
chondrial membrane complex (Humphries et al., 2005). This com-
plex imports precursor proteins into mitochondria (Koehler et al.,
1999). Mitochondrial dysfunction may play a signiﬁcant role in
cognitive decline and AD-related pathology (“The mitochondrial
cascade hypothesis”; Swerdlow and Kahn, 2004). APOE and
TOMM40 may interact to affect aspects of mitochondrial function
although mechanistically it is unclear exactly how (Roses et al.,
2010).
The rs10524523 locus (hereafter “523”) in the TOMM40 gene is
characterized by a variable number of T residues (“poly-T repeats”)
that can be classiﬁed into 3 different lengths: “short” (<20; “S”),
“long” (20e29; “L”), and “very-long” (30; “VL”; Lutz et al., 2010).
Roses et al. (2010) showed with phylogenetic mapping analyses
that TOMM40 523 poly-T repeat length was strongly linked to APOE
ε genotype in humans: ε4 is most commonly linked to the 523 L
allele, with ε3 linked to either S or VL alleles in different evolu-
tionary clades. The rarer ε2 allele appeared similar to ε3 although
further research is required in large samples (Roses et al., 2010).
Studies have tested for association between TOMM40 523 repeat
length and different brain-related phenotypes independently from
APOE. For example, age of AD onset (Roses et al., 2010) and worse
cognitive aging (Schiepers et al., 2012), were examined. However,
reports vary in showing protective (Johnson et al., 2011), null (Chu
et al., 2011), or deleterious (Cruchaga et al., 2011) effects of the S
allele. See Roses et al. (2013) for a discussion of early studies.
Diffusion-tensor magnetic resonance imaging (MRI) and quan-
titative tractography allow examination of brain white matter
microstructure in vivo in speciﬁc white matter tracts thought to
relate to cognitive functions (Behrens et al., 2007; Pierpaoli et al.,
1996). Diffusion-tensor imaging (DTI) measures the magnitude
and directional coherence of water molecule diffusion and, because
water molecule diffusion is preferentially constrained along theprincipal ﬁber direction by axonal membranes and myelin sheaths,
this property can be used to assess white matter structural integrity
(Behrens et al., 2007; Pierpaoli et al., 1996). Fractional anisotropy
(FA) is an example of a common DTI-derivedmetric, and reﬂects the
level of directional coherence of water molecule diffusion (Pierpaoli
et al., 1996). Speciﬁcally, FA measures are high in healthy, struc-
turally intact, coherently organized white matter, but fall in
diseased tissue. Associations between the APOE gene and white
matter integrity have been investigated previously (see Gold et al.,
2012 for a review of signiﬁcant ﬁndings; also Felsky and Voineskos,
2013). To our knowledge, the largest previous study had 203 par-
ticipants (Westlye et al., 2012; mean age ¼ 47.6 years, standard
deviation ¼ 14.9). That report found widespread differences in
microstructural integrity depending on APOE status. Controlling for
age and gender, ε3/ε4 carriers had lower white matter integrity (vs.
ε3/ε3) in the brainstem, basal temporal lobe, internal capsule,
anterior parts of the corpus callosum, forceps minor, superior lon-
gitudinal fasciculus, occipital, and corticospinal motor pathways
(Cohen’s d range ¼ 0.77e0.79; “medium-large effects”). We found
no studies that examined the independent effects of the TOMM40
523 poly-T repeat.
The present study aims to investigate the effects of APOE and
TOMM40 genotypes on brain white matter integrity as assessed
using quantitative tractography in a large, age-homogenous sample
of relatively healthy older people. Fourteen major projection,
commissural, and association ﬁber tracts were examined that have
previously been signiﬁcantly associated with cognitive abilities in
this sample (Penke et al., 2012).2. Methods
2.1. Sample and procedure
The LBC1936 is a cohort of 1091 generally healthy community-
dwelling adults, 1028 of whom completed the Moray House Test
no.12 (MHT) of verbal reasoning as part of the Scottish Mental
Survey 1947 at a mean age of 11 years. The recruitment and testing
of this sample has been detailed in previous protocol papers (Deary
et al., 2007, 2012). All the LBC1936 participants were born in 1936
and most resided in the Edinburgh (Lothian) area of Scotland when
recruited in older adulthood. In the ﬁrst wave of the LBC1936 study
(“wave 1”), at around the age 70 years, they were retested on the
MHT in addition to other detailed cognitive, sociodemographic, and
physical assessments (Deary et al., 2007). Around 3 years later, 866
members of the cohort returned for re-testing in the second wave
of the study (“wave 2”). At this point, in addition to repeating the
wave 1 assessments, most of the participants also underwent
detailed structural brain MRI (Wardlaw et al., 2011). At both waves,
participants were screened for cognitive impairmentwith theMini-
Mental State Examination (MMSE), with scores under 24 used to
indicate possible dementia (Folstein et al., 1975). Medical history
was elicited via interview, including hypertension, diabetes, stroke,
hypercholesterolemia, and history of any other vascular disease
(e.g., heart attack). All subjects gave written, informed consent after
the nature of the procedures had been explained to them.2.2. Cognitive assessment
Moray House Test: This was completed in 1947 at a mean age of
11 years. This test of general cognitive ability has a 45-minute time
limit and has a maximum score of 76, with a predominance of
verbal reasoning items, and some numerical and visuospatial items
also included (Deary et al., 2007). MHT scores were adjusted for age
in days at the time of assessment, and standardized to an IQ score
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LBC1936 sample.
2.3. Genotyping
For APOE, DNA was isolated from whole blood, and the target
sequences for rs7412 and rs429358 were genotyped with TaqMan
technology (Invitrogen website, 2012). These 2 SNPs form the APOE
ε2/ε3/ε4 haplotype (commonly and herein simply “genotype”).
TOMM40 523 poly-T repeat length was genotyped by the labo-
ratory of Dr. Ornit Chiba-Falek (Duke University, NC, USA) using a
method described previously (Linnertz et al., 2012). Brieﬂy, each
genomic DNA sample was ampliﬁed by the polymerase chain
reaction using ﬂuorescently labeled forward 50FAM-TGCTGACCT-
CAAGCTGTCCTG-30 and reverse 50-GAGGCTGAGAAGGGAGGATT-
30primers. Genotypes were determined on an ABI 3730 DNA
Analyzer, using GeneMapper version 4.0 software (Applied Bio-
systems, Foster City, California, USA) for fragment analysis by the
ampliﬁed fragment length polymorphism method validated for
research studies and commercially available.
2.4. Diffusion MRI and tractography analysis
Participants underwent whole brain diffusion MRI acquired
using a GE Signa Horizon HDxt 1.5-T clinical scanner (General
Electric, Milwaukee, USA) equipped with a self-shielding gradient
set (33 mT m1 maximum gradient strength) and manufacturer-
supplied 8-channel phased-array head coil (Wardlaw et al., 2011).
The protocol consisted of 7 T2-weighted (b ¼ 0 s mm2) and sets of
diffusion-weighted (b ¼ 1000 s mm2) axial single-shot spin-echo
echo-planar volumes acquired with diffusion gradients applied in
64 noncollinear directions. Seventy-two contiguous slices of 2 mm
thickness were collected with a ﬁeld of view of 256  256 mm and
acquisition matrix of 128  128, giving 2 mm isotropic voxel
resolution.
The diffusion MRI data were preprocessed using FMRIB Sofware
Library (FSL) tools (Oxford, UK; Nufﬁeld Department of Clinical
Neurosciences, 2012) to extract the brain, remove bulk patient mo-
tion and eddy current induced artifacts, and generate parametric
maps of FA. Underlying tractography connectivity data were gener-
ated using BedpostX/ProbTrackXwith the default settings of a 2-ﬁber
model per voxel, and 5000 probabilistic streamlines with a ﬁxed
separationof 0.5mmbetween successive points (Behrens et al., 2007).
Fourteen tracts were identiﬁed using probabilistic neighbor-
hood tractography, an approach for automatic and reproducible
tract segmentation (Clayden et al., 2007), as implemented in the
TractoR package for ﬁber tracking analysis (Clayden et al., 2011;
Tractography with R website, 2012). This method segments the
same fasciculus-of-interest in different individuals by identifying
the best-matched tract from a group of “candidate” tracts that most
closely resembles a predeﬁned reference tract in terms of both
length and shape. This approach has advantages over tract-based
spatial statistics in that each tract is segmented in native rather
than standard space, therefore providing a better representation of
speciﬁc tract anatomy in each individual (Bastin et al., 2013). Tracts
assessed were the genu and splenium of corpus callosum, and
bilateral anterior thalamic radiations, ventral and rostral cingulum
bundles, and arcuate, uncinate, and inferior longitudinal fasciculi.
Tract masks generated by this method were overlaid on the FA
parametric map and tract-averaged values, weighted by the
connection probability, were determined for each tract in every
subject.
To ensure that the segmented tracts were anatomically plausible
representations of the fasciculi-of-interest, a researcher visually
inspected all tract masks blind to the other study variables andexcluded those with aberrant or truncated pathways. In general,
probabilistic neighborhood tractography was able to segment the
14 tracts-of-interest reliably in most of the subjects, with tracts that
did not meet quality criteria, such as truncation or failing to follow
the expected path, ranging from 0.3% for the splenium of the corpus
callosum to 16% for the left anterior thalamic radiation, with amean
of 5%.
To permit principal components analysis (PCA) on the tractog-
raphy data, participants with up to 2 missing values from speciﬁc
tracts had data replaced with the mean value for that tract. PCAwas
conducted on tract-averaged water diffusion parameters for 12
pathways, giving a clear single-factor model for FA (gfa) that
accounted for 38.78% of the overall variance. The ventral cingulum
was not included in the PCA because the rostral and ventral cingula
are subdivisions of the same tract. General white matter integrity
factors have previously been found to be associated with cognitive
abilities in this sample (Penke et al., 2010, 2012).
3. Statistical analysis
3.1. Statistical models
Three statistical models were used to investigate the effect of
APOE and TOMM40 genetic variants (the independent variables) on
tract-averaged FA values (the dependent variables) for the 14 tracts
and gfa. First, allmodels controlled for covariates of genderandage in
days at neuroimaging (“model 1”). Signiﬁcant effects were re-tested
controlling for the additional covariate of age-11 IQ (“model 2”). This
reduces the chance of results being affected by reverse causality,
where differences in early-life cognitive ability might, perhaps via
inﬂuence on health-related variables, inﬂuence brain changes in
later life (Deary et al., 2007; Shenkin et al., 2003). Finally, signiﬁcant
effects were re-tested controlling for the following covariates in
addition to those in model 2; self-reported history of hypertension,
stroke, type-2 diabetes, hypercholesterolemia, and all-inclusive
vascular disease (“model 3”; Schiepers et al., 2012). This reduces
the chance that any signiﬁcant associations occur as secondary to
genetic associations with vascular pathology.
An online calculator was used to perform tests of Har-
dyeWeinberg equilibrium and determine minor allele frequencies
(Calculator; Hardy Weinberg equilibrium, 2012). Data were other-
wise analyzed with IBM Statistical Package for the Social Sciences,
version 19.0 (SPSS Inc, Chicago, USA). Speciﬁcally, univariate gen-
eral linear models (GLM) tested the ﬁxed effects of separate APOE
and TOMM40 genotypes upon the outcome variables, namely white
matter integrity parameters. Outliers of more than 3 standard de-
viations frommean values were removed from age-11 IQ (n¼ 7). To
protect against type 1 errors, false discovery rate (FDR) was used to
estimate the number of signiﬁcant ﬁndings in the context of mul-
tiple testing (Benjamini et al., 1995). A Microsoft excel program
(Pike, 2011) was used to conduct classical 1-stage FDR based on
associations with white matter integrity. All p-values are raw unless
stated as being FDR-adjusted. p-values < 0.05 were considered to
be “nominally” signiﬁcant. Final results did not differ whether FDR
was applied separately to individual sets of analyses (i.e., APOE and
then TOMM40 sub-analyses), or to a collated list of all analyses.
3.2. APOE analysis
The APOE ε genotype is composed of any 2 of the ε2 (protective),
ε3 (neutral), and ε4 (risk) alleles. The ﬁrst analytic step tested the
effects of APOE ε4 allele presence versus absence, that is, pooled ε2/
ε4, ε3/ε4, and ε4/ε4 genotypes versus pooled ε2/ε2, ε2/ε3, and ε3/ε3
(“step 1”). The second analytic step tested genotypes, which may be
protective for neurodegenerative pathology, compared with the
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2”; Deary et al., 2004; Luciano et al., 2009).
3.3. TOMM40 analysis
The variable-length poly-T repeat rs10524523 (“523”) was split
into 3 categories: “S” (<20 T residues), “L” (20), and “VL” (30)
(Lutz et al., 2010), of which the S allele may ormay not be protective
in terms of neurodegenerative pathology (Bruno et al., 2011; Chu
et al., 2011). In the ﬁrst analytic step, in the whole sample, a GLM
tested for a signiﬁcant effect of TOMM40 523-genotype (i.e., S/S; S/L;
L/L; L/VL; VL/VL; “step 1”).
To investigate the effects of TOMM40 523 repeat length inde-
pendent of biological variation in APOE genotype, analysis then
focused separately on 2 different large APOE ε genotype subgroups;
ﬁrstly participants with the ε3/ε4 genotype (“step 2”). Devi et al.
(2006) reported that this genotype had the highest accumulation
of amyloid precursor protein in AD brain mitochondria (vs. ε3/ε3
and ε4/ε4 genotypes; assessed by immunoblot analysis), and this
correlated strongly with 2 indicators of mitochondrial dysfunction
(cytochrome C oxidase activity and reactive oxygen species
hydrogen peroxide; “H2O2”). In terms of a possible interaction be-
tween amyloid precursor protein accumulation and mitochondria
translocase processes, it is not known if the S allele may offset or
interact biologically with the ε3/ε4 genotype (Bruno et al., 2011).
Finally, analysis focused on participants with the neutral APOE ge-
notype (ε3/ε3) (“step 3”), because this eliminates variance associ-
ated with protective and risk APOE alleles (Roses et al., 2010).
Examining the effects of TOMM40 523 in APOE subgroups means
that any signiﬁcant associations cannot logically be attributed to
APOE genotypic variation.
In large samples of Caucasians, linkage between the APOE ε ge-
notype and TOMM40 523 length (i.e., ε4 links primarily to “L”, ε3
primarily to “S” or “VL”) is such that in the APOE ε3/ε3 genotype,
relatively few L carriers would be predicted while in the ε3/ε4 ge-
notype typically 1 L allele would be predicted in addition to either
an S or VL allele (Linnertz et al., 2012). Slight errors in poly-T repeat
length measurement may occur through polymerase chain reaction
“slippage” and this may result in repeat lengths that are close to the
L and/or VL boundary being incorrectly classiﬁed (Linnertz et al.,
2012). To attempt to control for this, in steps 2 and 3, the L and
VL alleles were pooled into an “L*” group; participants with the S/S
genotype were compared with those carrying only 1 S allele
(pooled S/L and S/VL; hereinafter S/L*), and also against participantsTable 1
Apolipoprotein-ε (APOE) and white matter integrity
White matter tract (FA) Step 1
ε4 allele presence (vs. absence)
(df) F statistics p
General factor (gfa) (1, 524) ¼ 0.83 0.362
Genu of the corpus callosum (1, 559) ¼ 0.20 0.659
Splenium of the corpus callosum (1, 575) ¼ 0.07 0.788
Left arcuate fasciculus (1, 552) ¼ 0.00 0.987
Right arcuate fasciculus. (1, 500) ¼ 0.17 0.683
Left anterior thalamic radiation (1, 479) ¼ 0.00 0.962
Right anterior thalamic radiation (1, 556) ¼ 0.11 0.745
Left uncinate fasciculus. (1, 492) ¼ 1.57 0.212
Right uncinate fasciculus. (1, 545) ¼ 0.00 0.990
Left rostral cingulum (1, 556) ¼ 0.06 0.803
Right rostral cingulum (1, 564) ¼ 0.09 0.760
Left ventral cingulum (1, 561) ¼ 2.36 0.125
Right ventral cingulum (1, 570) ¼ 5.48 0.020
Left inferior longitudinal fasciculus (1, 575) ¼ 5.04 0.025
Right inferior longitudinal fasciculus (1, 577) ¼ 0.27 0.604
Age in days at the time of testing and gender is statistically controlled. Associations sign
Key: df, degrees of freedom; FA, fractional anisotropy.carrying no S alleles (pooled L/L, L/VL, and VL/VL; hereinafter L*/L*;
Caselli et al., 2012). A GLM therefore tested for effects of S-allele
group (S/S; S/L*; L*/L*) on brain white matter integrity variables in
steps 2 and 3 (APOE ε3/ε4 and ε3/ε3 subgroups, respectively).4. Results
4.1. Descriptive statistics
Of the 1091 total LBC1936 participants, 866 attended waves 1
and 2, and 731 underwent neuroimaging. Individuals who reported
being ambidextrous or left handed at either “wave 1” or “wave 2”
(n¼ 50), or had MMSE scores below 24 (n ¼ 5), or did not complete
the MMSE at wave 2 (n ¼ 1) were excluded. No participants had a
history of dementia. Overall, this left 675 participants, of which 642
and 652 participants had successful genotyping for APOE and
TOMM40, respectively.
APOE had allele frequencies of ε2 ¼ 7.4%, ε3 ¼ 77.0%, and ε4 ¼
15.6%, with genotype frequencies of: ε2/ε2 ¼ 2 (0.3%), ε2/ε3 ¼ 77
(12.0%), ε2/ε4 ¼ 14 (2.2%), ε3/ε3 ¼ 376 (58.6%), ε3/ε4 ¼ 160 (24.9%),
and ε4/ε4 ¼ 13 (2.0%). TOMM40 523 had allele frequencies of S ¼
41.3%, L¼ 15.3%, and VL¼ 43.4%, with genotype frequencies of S/S¼
102 (15.6%), S/L ¼ 94 (14.4%), S/VL ¼ 240 (36.8%), L/L ¼ 15 (2.3%), L/
VL¼ 76 (11.7%), and VL/VL¼ 125 (19.2%). Exact tests conﬁrmed that
APOE and TOMM40 were in HardyeWeinberg equilibrium (p-
values ¼ 0.656 and 0.273, respectively). Sample demographics for
different APOE and TOMM40 genotypes are displayed in
Supplementary Table 1.4.2. APOE and quantitative tractography
For the APOE ε4 present versus absent comparison, signiﬁcant
effects were found for 2 tracts, where presence of the ε4 allele was
associated with poorer white matter integrity in the predicted di-
rection (see Tables 1 and 3).
The ﬁrst signiﬁcant effect was found in the right ventral
cingulum (F [1, 570] ¼ 5.48, p ¼ 0.020, and partial h2 ¼ 0.010). This
survived correction for age-11 IQ (F [1, 535] ¼ 4.17, p ¼ 0.042, and
partial h2 ¼ 0.008), and vascular disease history (F [1, 530] ¼ 3.90,
p ¼ 0.049, and partial h2 ¼ 0.007).
The second signiﬁcant effect was found in the left inferior lon-
gitudinal fasciculus (F [1, 575] ¼ 5.04, p ¼ 0.025, and partial h2 ¼
0.009). This survived correction for age-11 IQ (F [1, 539] ¼ 7.30, p ¼Step 2
APOE ε2/ε3 and ε2/ε2 (vs. ε3/ε3)
Partial h2 (df) F statistics p Partial h2
0.002 (1, 376) ¼ 0.12 0.730 0.000
0.000 (1, 399) ¼ 0.26 0.612 0.001
0.000 (1, 409) ¼ 0.00 0.985 0.000
0.000 (1, 393) ¼ 0.62 0.432 0.002
0.000 (1, 356) ¼ 0.03 0.873 0.000
0.000 (1, 341) ¼ 0.00 0.957 0.000
0.000 (1, 395) ¼ 0.00 0.979 0.000
0.003 (1, 348) ¼ 0.00 0.956 0.000
0.000 (1, 390) ¼ 0.03 0.873 0.000
0.000 (1, 394) ¼ 0.27 0.604 0.001
0.000 (1, 402) ¼ 0.28 0.603 0.001
0.004 (1, 396) ¼ 1.05 0.305 0.003
0.010 (1, 404) ¼ 1.19 0.277 0.003
0.009 (1, 407) ¼ 0.17 0.689 0.000
0.000 (1, 409) ¼ 1.07 0.303 0.003
iﬁcant at p < 0.05 are given italics.
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534] ¼ 7.00, p ¼ 0.008, and partial h2 ¼ 0.013).
There was no main effect of the pooled ε2/ε3 and ε2/ε2 geno-
types (vs. ε3/ε3) on the white matter integrity of any of the tracts
analyzed (see Table 1).
4.3. TOMM40 523 length and quantitative tractography
In the whole sample (step 1), 2 signiﬁcant effects of TOMM40
523 genotype were found (see Tables 2 and 3). The ﬁrst signiﬁcant
effect was found in the left ventral cingulum (F [5, 564] ¼ 2.60, p ¼
0.025, and partial h2 ¼ 0.022). This effect survived correction for
additional covariates of age-11 IQ (F [5, 531] ¼ 2.57, p ¼ 0.026, and
partial h2 ¼ 0.024), and vascular disease history (F [5, 526] ¼ 2.79,
p¼ 0.017, and partial h2¼ 0.026). Post hoc tests showed that the S/L
genotype had signiﬁcantly lower FA compared with S/S (p ¼ 0.029),
S/VL (p¼ 0.008), L/L (p¼ 0.033), and L/VL (p¼ 0.003) genotypes (all
other comparisons were p > 0.05).
The second signiﬁcant effect was found in the right rostral
cingulum (F [5, 568] ¼ 2.99, p ¼ 0.011, and partial h2 ¼ 0.026). This
effect survived correction for age-11 IQ (F [5, 533]¼ 3.73, p¼ 0.003,
and partial h2 ¼ 0.034), and vascular disease history (F [5, 528] ¼
3.62, p ¼ 0.003, and partial h2 ¼ 0.033). Post hoc tests showed that
the S/L genotype had signiﬁcantly lower FA compared with the S/VL
(p ¼ 0.011), and L/VL (p ¼ 0.026) genotypes, with VL/VL having
signiﬁcantly lower FA compared with L/VL (p ¼ 0.017; all other
comparisons were p > 0.05).
To determine whether association between TOMM40 523 length
and white matter tract integrity was driven by linkage with APOE,
the previously mentioned associations were re-tested controlling
for presence of the ε4 allele. Controlling for age, gender, and APOE ε4
presence, the main effect of TOMM40 523 length remained for both
right rostral cingulum FA (F [5, 547] ¼ 3.00, p ¼ 0.011, and partial
h2 ¼ 0.024) and left ventral cingulum FA (F [5, 544] ¼ 3.45, p ¼
0.004, and partial h2 ¼ 0.031).
In ε3/ε4 carriers (step 2), 4 signiﬁcant effects of TOMM40 523
length were found; these suggested a deleterious effect of the S/L*
genotype versus L*/L* (see Table 2). This indicates that possessing
an S allele is associatedwith lowerwhitematter integrity compared
with possessing only L or VL alleles (as pooled into the “L*” group).
Note that the ε3/ε4 group had no S/S homozygotes.
The ﬁrst signiﬁcant effect was found for gfa (F [1, 122] ¼ 4.95, p¼
0.028, and partial h2 ¼ 0.039). This survived correction for addi-
tional covariates of age-11 IQ (F [1,114]¼ 5.35, p¼ 0.023, and partialTable 2
Translocase of outer membrane 40 (TOMM40) “523” length and white matter integrity
White matter tract (FA) Whole sample AP
(df) F statistics p Partial h2 (d
General factor (gfa) (5, 529) ¼ 2.11 0.063 0.020 (1,
Genu of the corpus callosum (5, 564) ¼ 1.83 0.105 0.016 (1,
Splenium of the corpus callosum (5, 580) ¼ 0.20 0.963 0.002 (1,
Left arcuate fasciculus (5, 557) ¼ 0.64 0.669 0.006 (1,
Right arcuate fasciculus. (5, 507) ¼ 0.50 0.774 0.005 (1,
Left anterior thalamic radiation (5, 481) ¼ 1.68 0.139 0.017 (1,
Right anterior thalamic radiation (5, 560) ¼ 1.47 0.197 0.013 (1,
Left uncinate fasciculus. (5, 594) ¼ 1.61 0.157 0.016 (1,
Right uncinate fasciculus. (5, 549) ¼ 1.13 0.343 0.010 (1,
Left rostral cingulum (5, 561) ¼ 2.09 0.065 0.018 (1,
Right rostral cingulum (5, 568) ¼ 2.99 0.011 0.026 (1,
Left ventral cingulum (5, 564) ¼ 2.56 0.025 0.022 (1,
Right ventral cingulum (5, 576) ¼ 0.75 0.584 0.006 (1,
Left inferior longitudinal fasciculus (5, 580) ¼ 0.88 0.492 0.008 (1,
Right inferior longitudinal fasciculus (5, 581) ¼ 0.66 0.655 0.006 (1,
Age in days at the time of testing and gender is statistically controlled. Associations sign
Key: df, degrees of freedom; FA, fractional anisotropy.h2¼ 0.045) and vascular disease history (F [1, 109]¼ 5.84, p¼ 0.017,
and partial h2 ¼ 0.051).
The second signiﬁcant effect was found in the left uncinate
fasciculus (F [1,117]¼ 4.16, p¼ 0.044, and partial h2¼ 0.034), which
did not survive the addition of the covariate of age-11 IQ (F [1,
108] ¼ 3.68, p ¼ 0.058, and partial h2 ¼ 0.033). However, the initial
signiﬁcant effect remained when including vascular disease history
but not age-11 IQ as a covariate, (F [1,112] ¼ 4.12, p ¼ 0.045, and
partial h2 ¼ 0.035).
The third signiﬁcant effect was found in the left rostral cingulum
(F [1, 133] ¼ 5.51, p ¼ 0.020, and partial h2 ¼ 0.040). This survived
correction for additional covariates of age-11 IQ (F [1, 124] ¼ 5.50,
p ¼ 0.021, and partial h2 ¼ 0.042) and vascular disease history (F [1,
119] ¼ 5.83, p ¼ 0.017, and partial h2 ¼ 0.047).
The fourth andﬁnal signiﬁcant effectwas found in the left ventral
cingulum (F [1, 136] ¼ 13.35, p < 0.001, and partial h2 ¼ 0.089) and
remained after correction for additional covariates of age-11 IQ (F [1,
125]¼14.40,p¼<0.001, andpartialh2¼0.103) and vasculardisease
history (F [1, 120] ¼ 15.75, p ¼ <0.001, and partial h2 ¼ 0.116).
No signiﬁcant effects of the TOMM40 523 poly-T repeat length
polymorphism were found at step 3 (i.e., in the ε3/ε3 genotype)
(Table 2).
4.4. Correction for multiple testing
With FDR correction, all nominally signiﬁcant (uncorrected)
effects attenuated to nonsigniﬁcance except for the main effect of
TOMM40 523 S/L* versus L*/L* on left ventral cingulum FA in APOE
ε3/ε4 carriers (models 1, 2, and 3; FDR-adjusted p-values all ¼
0.017).
5. Discussion
5.1. Overview
The present study investigated the effects of variants in 2 genes
upon brain white matter tract integrity in a large sample of non-
demented, community-dwelling people in their early 70s. These
gene loci were APOE ε and the TOMM40 523 poly-T repeat. The
current report is the largest examination of the APOE locus and
white matter integrity in a single study (Gold et al., 2012; Westlye
et al., 2012) and therefore adds a signiﬁcant amount of new data
to the literature. No previous studies have examined TOMM40 523
in relation to this phenotype.OE ε3/ε4 genotype APOE ε3/ε3 genotype
f) F statistics p Partial h2 (df) F statistics p Partial h2
122) ¼ 4.95 0.028 0.039 (2, 303) ¼ 1.04 0.356 0.007
131) ¼ 2.42 0.122 0.018 (2, 321) ¼ 0.92 0.401 0.006
136) ¼ 1.56 0.214 0.011 (2, 331) ¼ 0.21 0.810 0.001
131) ¼ 0.92 0.339 0.007 (2, 317) ¼ 0.62 0.539 0.004
117) ¼ 0.30 0.584 0.003 (2, 289) ¼ 0.84 0.435 0.006
110) ¼ 2.68 0.104 0.024 (2, 277) ¼ 0.19 0.826 0.001
132) ¼ 3.22 0.075 0.024 (2, 320) ¼ 2.06 0.129 0.013
117) ¼ 4.16 0.044 0.034 (2, 279) ¼ 0.49 0.616 0.003
128) ¼ 1.39 0.240 0.011 (2, 314) ¼ 0.88 0.416 0.006
133) ¼ 5.51 0.020 0.040 (2, 317) ¼ 1.87 0.156 0.012
133) ¼ 1.96 0.164 0.015 (2, 326) ¼ 2.87 0.058 0.017
136) ¼ 13.35 <0.001 0.089 (2, 322) ¼ 0.72 0.487 0.004
137) ¼ 0.00 0.980 0.000 (2, 326) ¼ 0.83 0.439 0.005
138) ¼ 0.12 0.725 0.001 (2, 330) ¼ 0.83 0.436 0.995
138) ¼ 0.37 0.547 0.003 (2, 331) ¼ 0.81 0.448 0.005
iﬁcant at p <0.05 are given italics.
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D.M. Lyall et al. / Neurobiology of Aging 35 (2014) 1513.e25e1513.e331513.e30The present study found signiﬁcant effects of the APOE ε4 risk
allele in the predicted deleterious direction on: (1) the right
ventral cingulum; and (2) the left inferior longitudinal fasciculus.
The ventral cingulum is a parieto-occipital tract connecting the
cingulate cortex with parahippocampal gyri and terminating in the
anterior part of the medial temporal lobes. The left inferior lon-
gitudinal fasciculus connects occipital and temporal areas
including the hippocampus (Catani and Thiebaut de Schotten,
2008).
TOMM40 523 poly-T repeat length genotype had signiﬁcant ef-
fects in the whole sample and in the subgroup of participants that
possessed the APOE ε3/ε4 genotype. In the whole sample, signiﬁ-
cant effects were found in the left ventral cingulum and the right
rostral cingulum, both primarily driven by the S and/or L genotype
being associated with signiﬁcantly lower FA compared with other
TOMM40 523 length genotypes. These signiﬁcant associations sur-
vived statistical correction for presence of the APOE ε4 allele,
however were not signiﬁcant in the subgroup of participants with
the “neutral” ε3/ε3 genotype, suggesting they are either: (1) un-
likely to be truly independent of APOE genotype, and reﬂect type 1
error; or (2) sensitive to reductions in sample size. Larger samples
of individuals with the ε3/ε3 genotypewould be required to address
this further.
In APOE ε3/ε4 carriers, a signiﬁcant deleterious effect of pos-
sessing an S allele (vs. not) was found in: the (1) left uncinate
fasciculus; (2) left rostral cingulum; (3) left ventral cingulum; and
(4) general factor of white matter integrity (gfa). The uncinate
fasciculus connects the anterior temporal lobe to medial and lateral
orbitofrontal cortex, whereas the rostral cingulum projects from the
cingulate to orbitofrontal cortices (Catani and Thiebaut de Schotten,
2008). The gfa parameter, which is determined from PCA of the
tract-averaged FA values for 12 major ﬁber pathways in each sub-
ject, shows that the integrity of white matter is to a substantial
degree shared across tracts throughout the brain, possibly indi-
cating shared inﬂuences (Lopez et al., 2012; Penke et al., 2012).
Most of the reported associations remained when corrected for
history of vascular disease (e.g., history of stroke, etc.) and child-
hood intelligence. Corrected for multiple testing, only the delete-
rious effect of the TOMM40 523 S allele (vs. pooled noncarriers, in
the APOE ε3/ε4 subgroup analysis) upon left ventral cingulum
integrity remained signiﬁcant. White matter diffusion tensor
phenotypes are highly correlated as indicated by the gfa factor. This
can make correction for multiple testing overly conservative;
therefore, for different reasons, nominal and adjusted effects
require caution in their interpretation (Nyholt et al., 2001;
Williams and Haines, 2011). All ﬁndings reported therefore
require replication in large independent samples.
5.2. APOE ε genotype
The present study partially replicates previous associations be-
tween ε4 and tracts associated with temporal lobe structures
(before correction for multiple testing); speciﬁcally the inferior
longitudinal fasciculus (Gold et al., 2010; Smith et al., 2010), and
ventral cingulum (Smith et al., 2010; “posterior cingulum”). It is
possible that the effects of APOE seen here are indicative of pro-
dromal AD in the current sample. However, it is unclear why the left
inferior longitudinal fasciculus and right ventral cingulumwould be
particularly vulnerable to the effects of the APOE ε4 allele, and not
the integrity of other white matter tracts; these ﬁndingsmay reﬂect
a degree of type-1 error as reﬂected by their attenuation to non-
signiﬁcance when corrected with FDR. Common genetic variants
typically have small effect sizes, and it is possible that the current
sampleewhile relatively largeemay not be sufﬁciently powered to
detect small effects.
D.M. Lyall et al. / Neurobiology of Aging 35 (2014) 1513.e25e1513.e33 1513.e31The present study is the largest assessment of APOE and white
matter integrity to date and reports more circumscribed effects of
ε4 allele possession compared with previous reports (Gold et al.,
2012). This could relate to the relatively large sample size and ho-
mogenous age ranges assessed here compared with previous
studies. Larger samples are likely to be more reliable, and wide age
ranges could include the cumulative inﬂuence of subtle age-related
processes; correlation between age and brain phenotypes is un-
likely to be completely unique and rather may be via processes
associated with chronological age; it is therefore unlikely that sta-
tistically controlling for age would completely capture this (Hofer
and Sliwinski, 2001). Discrepancies may also relate to differences
between image analysis methods (e.g., tract-based spatial statistics;
Westlye et al., 2012) versus probabilistic neighborhood tractog-
raphy used here. The present study does not interrogate white
matter integrity across the whole brain and therefore cannot
exclude the possibility of signiﬁcant ε4 effects in regions that were
not assessed, such as the fornix. Regardless, the nominally signiﬁ-
cant effects observed here were weaker and more speciﬁc than
would have been expected when compared with the “medium-
large” effects reported previously (Gold et al., 2012; Westlye et al.,
2012).
5.3. TOMM40 523 poly-T repeat
Associations between the TOMM40 523 poly-T repeat and white
matter integrity have not been investigated by previous studies.
The previously mentioned results indicate an independent delete-
rious effect of the TOMM40 523 S allele in APOE ε3/ε4 but not ε3/ε3
genotypes. This association is independent in the sense that any
deleterious effects of TOMM40 523 S allele possession (vs. non-
possession) cannot be causally attributed to linkage with APOE ε
alleles, because a speciﬁc stable subgroup was analyzed. Similar to
APOE, the tracts that showed negative association with the S allele
have been implicated in early AD pathology; the (left) uncinate
fasciculus, (left ventral) cingulum, and (left rostral) cingulum (Gold
et al., 2010; Heise et al., 2011; Smith et al., 2010). As with APOE, it is
unclear why these speciﬁc tracts (and not others) would be exclu-
sively affected by TOMM40 523 length. It is possible that the
TOMM40 523 associations seen here reﬂect early anatomic sub-
strates of AD; this sample does not currently have AD-relevant data
to address this possibility.
A signiﬁcant effect was found for gfa. This suggests that the
TOMM40 523 repeat may inﬂuence processes that are sufﬁciently
pleiotropic to affect general white matter integrity. Lopez et al.
(2012) conducted a pathway analysis on gfa based on the current
sample dataset (n¼ 535). The authors used the web-based gene set
enrichment analysis toolkit (WebGestalt; Duncan et al., 2010; Zhang
et al., 2005) to conduct enrichment analysis for gene ontology on
genes that were signiﬁcantly associated with gfa (n ¼ 173 genes,
p < 0.01). Twenty-three ontology categories had enriched gene
numbers, the most signiﬁcant of which were “calcium-dependent
cell-cell adhesion” (p ¼ 1.15  1011) and “synapse assembly”
(p ¼ 5.20  108). Speculatively, the nominally signiﬁcant associa-
tion between TOMM40 523 repeat length and gfamay relate to these
ontologies. Lopez et al. (2012) found that TOMM40 did not reach
gene signiﬁcance based on 19 SNPs; note, however, that report did
not directly assess variation in the poly-T repeat locus.
Signiﬁcant effects of TOMM40 523 length were found only in
the APOE ε3/ε4 genotype. The S allele may modulate the toxic
effects of APOE ε4 allele presence (Bruno et al., 2011). Crenshaw
et al. (2012) report a protective effect of the S allele on the age of
onset of mild cognitive impairment in ε3/ε4 participants, but in
contrast a deleterious effect of the S/S genotype > S/VL genotype
> VL/VL genotype in the ε3/ε3 and ε2/ε3 genotype. The effectwas signiﬁcant on age of onset distributions in 106 conversion
events using standard neuropsychological tests in a series of 508
Caucasians ascertained prospectively. It is unclear what drives
these differing directions; opposing deleterious, protective, and/
or null effects of the S allele have been reported in different
studies of AD risk, brain structure, and/or cognitive aging
phenotype reports (e.g., Cruchaga et al., 2011; Johnson et al.,
2011; Schiepers et al., 2012). Further study of poly-T repeat
biological function and signiﬁcance is required in large samples,
including those with AD, APOE, or age of disease onset data/or
age of disease onset data (Bekris et al., 2012; Cruchaga et al.,
2011; Hedskog et al., 2012).
5.4. Summary
The present study found relatively circumscribed nominal sig-
niﬁcant effects of the APOE ε and TOMM40 523 gene loci on brain
white matter integrity in the LBC1936. Most of these associations
attenuated when corrected for multiple testing. While this study is
relatively large for a brain imaging and/or genetics report, replica-
tion in large independent samples is required.
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